3 free views remaining today
obsolete transsexualism
ICD-10 Codes
Related ICD-10:
Description
The Obsolete Concept of Transsexualism
Transsexualism, as a medical and psychological concept, has undergone significant changes over the years. In the past, it was considered a distinct category of gender identity disorder, but its relevance and accuracy have been questioned in recent times.
- Historical Context: The term "transsexual" was first coined by Magnus Hirschfeld in 1910 to describe individuals who identified with a different sex than their assigned one at birth (8). Initially, it referred to people who sought medical treatment to transition from one sex to another.
- Medicalization and Pathologizing: In the mid-20th century, transsexualism was pathologized and medicalized, leading to its inclusion in psychiatric and psychological literature as a mental health disorder (3). This approach viewed transsexuality as a problem that needed to be "cured" through medical intervention.
- Categorization and Diagnosis: Transsexualism was often diagnosed using outdated categorizations such as transvestism, gender dysphoria, and intersex. These labels were used to describe individuals who engaged in cross-dressing or sex-changing behaviors (3).
- Evolution of Terminology: As societal attitudes towards gender identity have shifted, the term "transsexual" has become increasingly obsolete. The American Psychological Association (APA) no longer recognizes transsexualism as a distinct diagnosis (12). Instead, it recommends using the terms "gender dysphoria" or "gender incongruence" to describe individuals who experience discomfort with their assigned sex.
- Current Understanding: Today, the concept of transsexuality is seen as a part of the broader spectrum of gender identity and expression. The term "transsexual" is still used by some people to describe themselves, but it is no longer considered a medical or psychological diagnosis (14).
In summary, the concept of transsexualism has evolved significantly over time, from being a distinct medical and psychological category to becoming an outdated and obsolete term.
Additional Characteristics
- The term 'transsexual' was first coined by Magnus Hirschfeld in 1910
- Transsexualism was pathologized and medicalized, leading to its inclusion in psychiatric and psychological literature as a mental health disorder
- Transsexualism was often diagnosed using outdated categorizations such as transvestism, gender dysphoria, and intersex
- The American Psychological Association (APA) no longer recognizes transsexualism as a distinct diagnosis
- Today, the concept of transsexuality is seen as a part of the broader spectrum of gender identity and expression
Signs and Symptoms
Understanding Obsolete Transsexualism
Transsexualism, as defined in the past, refers to a condition where an individual experiences a strong and persistent discomfort with their assigned gender, often accompanied by a desire to change their physical appearance to align with their perceived gender identity. The following signs and symptoms were once associated with transsexualism:
- Distress and discomfort: A feeling of unease or dissatisfaction with one's assigned gender, leading to a desire for change (1).
- Cross-gender identification: A strong and persistent identification with the opposite sex, often accompanied by a sense of belonging to that sex (4).
- Discomfort with own genitalia: A dislike or discomfort with one's own genitalia, which can be a symptom of gender dysphoria (8).
- Preferential behaviors: Engaging in activities or behaviors typically associated with the opposite sex, such as dressing in clothes or engaging in hobbies that are not typical for one's assigned gender (8, 11).
- Desire for physical change: A desire to alter one's physical appearance through surgery or other means to align with one's perceived gender identity (6).
Important Notes
It is essential to note that the concept of transsexualism has evolved over time, and the term is no longer used in modern psychiatric classification systems. The DSM-5 replaced the diagnosis of Gender Identity Disorder (GID) with a new diagnosis called gender dysphoria, which encompasses a broader range of symptoms and experiences.
References:
- [1]
- [4]
- [6]
- [8]
- [11]
Additional Symptoms
- DISTRESS AND DISCOMFORT
- CROSS-GENDER IDENTIFICATION
- DISCOMFORT WITH OWN GENITALIA
- PREFERENTIAL BEHAVIORS
- DESIRE FOR PHYSICAL CHANGE
Diagnostic Tests
Treatment
Treatment of Transsexualism (Now Known as Gender Dysphoria)
In the past, the treatment for transsexualism involved hormone replacement therapy to align the individual's physical characteristics with their gender identity.
- Male-to-Female (MTF) Transsexuals: Hormone treatment for MTF individuals typically consisted of estrogen administration, which led to changes in secondary sex characteristics such as breast development and voice deepening [10].
- Female-to-Male (FTM) Transsexuals: On the other hand, hormone treatment for FTM individuals involved testosterone administration, resulting in changes such as facial hair growth, voice deepening, and muscle mass increase [8].
It's worth noting that these treatments were often referred to as "cross-sex hormone therapy" or "gender-affirming hormone therapy" [2]. However, with the evolution of medical understanding and terminology, transsexualism is now more commonly referred to as gender dysphoria.
Current Treatment Approaches
While the specific treatment approaches may have changed over time, the underlying principles of providing medical care that aligns with an individual's gender identity remain essential. Today, hormone replacement therapy continues to be a common treatment for individuals experiencing gender dysphoria [7].
However, it's also important to note that current medical guidelines emphasize the importance of comprehensive care, including psychological support and social transition, in addition to hormone therapy [6].
References
- [1] Meyer, G. (2020). Gender-affirming hormone therapy of female-to-male transsexual persons is based on testosterone administered as a transdermal gel or intramuscular depot.
- [2] Meyer, G. (2020). Gender-affirming hormone therapy in accordance with current clinical practice guidelines is efficient and safe.
- [3] Glintborg, D. (2021). In Europe, the most commonly prescribed androgen-lowering medication for feminization is CPA. Spironolactone is commonly prescribed in the US.
- [4] Oct 23, 2020 — Gender-affirming hormone therapy of female-to-male transsexual persons is based on testosterone administered as a transdermal gel or ...
- [8] In transgender men, gender-affirming hormone treatment consists in testosterone administration, following the general principle of hormone replacement treatment.
- [7] Oct 22, 2024 — Medical care for transgender adults may include long‐term testosterone or estrogen treatment to align secondary sex characteristics with gender ...
Recommended Medications
- hormone replacement therapy
- testosterone
- Testosterone
- estrogen
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Understanding Differential Diagnosis in Transsexualism
The concept of differential diagnosis in transsexualism refers to the process of distinguishing between different conditions that may present with similar symptoms or characteristics. In the context of transsexualism, differential diagnosis is crucial for accurate diagnosis and treatment.
Historical Context
In the past, transsexualism was considered a distinct psychiatric condition, but it has since been reclassified and renamed in various diagnostic manuals. The DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition) replaced the term "transsexualism" with "gender identity disorder" (GID), while the ICD-10 (International Classification of Diseases, 10th Revision) used the term "transsexualism."
Differential Diagnosis in Transsexualism
According to various sources [3][9][10], differential diagnosis in transsexualism involves distinguishing between conditions such as:
- Transvestism: A condition where an individual derives pleasure from dressing up in clothes typically associated with the opposite sex, but does not experience a strong desire to change their gender identity.
- Autogynephilia: A condition where an individual experiences a strong attraction to themselves as a female, often accompanied by a desire to live as a woman.
- Body dysmorphic disorder: A condition characterized by a preoccupation with perceived flaws in one's appearance.
Key Points
- Differential diagnosis is essential for accurate diagnosis and treatment of transsexualism.
- Transvestism, autogynephilia, and body dysmorphic disorder are conditions that may be mistaken for transsexualism.
- The DSM-IV and ICD-10 have reclassified and renamed transsexualism in their diagnostic manuals.
References
[3] Nicolosi, 2002 [9] Blanchard, 1989 [10] Levine, 1980
Additional Differential Diagnoses
- Autogynephilia
- body dysmorphic disorder
- transvestism
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_7331
- owl#annotatedSource
- t393856
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:10919
- core#notation
- DOID:10919
- IAO_0000115
- A gender identity disorder that is characterized by an individual's identification with a gender inconsistent or not culturally associated with their biological sex.
- rdf-schema#label
- obsolete transsexualism
- owl#deprecated
- true
- relatedICD
- http://example.org/icd10/F64.0
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.